RedHill Biopharma Announces Agreement with NIAID to Evaluate RHB-107 Against COVID-19

NEXT STORY
MERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
PREV STORY
Authentic Heroes To Supply Personal Protective Equipment To Front Line Service Providers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19

author_avatar
NASDAQ Market News

INNATE PHARMA: consolidated financial results for the year ended December 31, 2017

2017: CLINiCAL PROGRESS, Portfolio expansion and financial strength create the foundation for future growth ...

author_avatar
NASDAQ Market News

SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence

author_avatar
NASDAQ Market News